Inference, Inc. is founded on the belief that there is a need for quality biostatistics and data management services in the early phases of drug development. Our operations are anchored in our deep understanding of the Phase 1 and 2 trial objectives and the study designs that optimally address these objectives. Our understanding of the science and the regulatory expectations worldwide is reflected in the way we collect clinical data and how we make statistical inference.